Old Ayala Inc Asset Turnover Ratio (AYLA), as of fourth quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Old Ayala Inc   (AYLA)
 

Old Ayala Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Old Ayala Inc 's asset turnover ratio, the ratio that measures the ability of Old Ayala Inc 's assets to generate revenue, sequentially decreased to 0.04 in the fourth quarter (Dec 31 2022), which does not come as a surprise, as the Old Ayala Inc continue to experience difficult business climate.

Within sector 72 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2022 compared to the preceding quarter from 4056 to 4548.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AYLA Asset Turnover Ratio (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Asset Change -81.11 % -68.83 % -50.44 % -48.26 % -10.26 %
Y / Y Revenue Change -90.84 % -85.44 % -95.01 % -52.98 % 14.14 %
Asset Turnover Ratio (TTM) 0.04 0.06 0.06 0.07 0.07
AYLA's Total Ranking # 4548 # 4056 # 4428 # 4058 # 4425
Seq. Asset Change -45.52 % -40.64 % -21.61 % -25.48 % -10.09 %
Seq. Revenue Change 15.38 % 139.47 % -91.7 % -60.03 % 83.36 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 73
Healthcare Sector # 674
Overall Market # 4548

Asset Turnover Ratio Statistics
High Average Low
0.08 0.07 0.04
(Dec 31 2020)   (Dec 31 2022)




AYLA Company Profile • Back to AYLA Efficiency Comparisons • Compare AYLA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2022 Assets at quarter ending Dec 31 2022
Alpha Teknova Inc   0.24 $ 41.420  Millions$ 169.703  Millions
Telesis Bio Inc   0.24 $ 168.110  Millions$ 691.702  Millions
Arbutus Biopharma Corp  0.24 $ 39.019  Millions$ 162.519  Millions
Mirum Pharmaceuticals Inc   0.24 $ 77.062  Millions$ 323.159  Millions
Jaguar Health Inc   0.24 $ 11.956  Millions$ 50.383  Millions
Procept Biorobotics Corporation  0.24 $ 75.014  Millions$ 316.301  Millions
Novan Inc   0.24 $ 23.682  Millions$ 100.010  Millions
Ionis Pharmaceuticals Inc   0.24 $ 587.367  Millions$ 2,482.768  Millions
Biocorrx Inc   0.24 $ 0.214  Millions$ 0.905  Millions
Quotient Limited  0.24 $ 36.269  Millions$ 153.953  Millions
Palvella Therapeutics Inc   0.23 $ 25.902  Millions$ 111.519  Millions
Co diagnostics Inc   0.23 $ 34.218  Millions$ 150.730  Millions
Q Biomed inc   0.23 $ 0.284  Millions$ 1.256  Millions
Cryoport inc   0.23 $ 237.277  Millions$ 1,050.050  Millions
Ginkgo Bioworks Holdings Inc   0.23 $ 477.706  Millions$ 2,115.490  Millions
Agenus Inc  0.23 $ 98.024  Millions$ 435.014  Millions
Quanterix Corporation  0.22 $ 104.820  Millions$ 468.538  Millions
Twist Bioscience Corporation  0.22 $ 215.790  Millions$ 968.162  Millions
Fortress Biotech Inc   0.22 $ 75.743  Millions$ 347.437  Millions
Adaptive Biotechnologies Corporation  0.22 $ 185.308  Millions$ 851.413  Millions
Voyager Therapeutics Inc   0.22 $ 40.907  Millions$ 188.656  Millions
Dariohealth Corp   0.22 $ 27.656  Millions$ 127.549  Millions
Enanta Pharmaceuticals Inc  0.22 $ 82.097  Millions$ 378.744  Millions
Bio rad Laboratories Inc   0.21 $ 2,802.249  Millions$ 13,153.988  Millions
Revance Therapeutics Inc   0.21 $ 132.565  Millions$ 623.730  Millions
Kyntra Bio Inc   0.21 $ 140.734  Millions$ 662.912  Millions
Affimed N v   0.21 $ 46.315  Millions$ 224.573  Millions
Evoke Pharma Inc   0.21 $ 2.509  Millions$ 12.173  Millions
Regen Biopharma Inc   0.21 $ 0.126  Millions$ 0.610  Millions
Mymetics Corporation  0.20 $ 1.695  Millions$ 8.289  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.